Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [820]
News [1675]
Articles [258]
Editorials [5]
Conferences [139]
elearning [32]
Highlights from BGICC 2020
Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from BGICC 2020 ( Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020
Ductal carcinoma in situ, are we over-treating it?
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
Ductal carcinoma in situ, are we over-treating it? ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
Intraoperative radiotherapy for breast cancer
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
Intraoperative radiotherapy for breast cancer ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
Discussing the treatment of head and neck tumours in India
Dr Prateek Jain - Tata Medical Center, Kolkata, India
Discussing the treatment of head and neck tumours in India ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )
10 Jan 2020
Residual cancer burden after neoadjuvant therapy and long-term survival...
Prof William Symmans - MD Anderson Cancer Center, Houston, Texas
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer ( Prof William Symmans - MD Anderson Cancer Center, Houston, Texas )
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019
Pathologic complete response rates improved with the neoadjuvant and adjuvant...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
Pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembrolizumab in TNBC patients ( Prof Peter Schmid - St Bartholomew's Hospital London, London, UK )
18 Dec 2019
Addition of S-1 to post-operative endocrine therapy for patients with hormone...
Prof Masakazu Toi - Kyoto University, Kyoto, Japan
Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer ( Prof Masakazu Toi - Kyoto University, Kyoto, Japan )
18 Dec 2019
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause...
Prof Deborah Fenlon - Swansea University, Swansea, UK
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )
12 Dec 2019
JCOG: The Japan Clinical Oncology Group
Dr Tomonori Mizutani - Kyorin University, Mitaka, Tokyo
JCOG: The Japan Clinical Oncology Group ( Dr Tomonori Mizutani - Kyorin University, Mitaka, Tokyo )
4 Dec 2019
GOSAFE study: Quality of life and functional recovery of elderly patients after...
Dr Nicole Saur - University of Pennsylvania, Philadelphia, USA
GOSAFE study: Quality of life and functional recovery of elderly patients after major cancer surgery ( Dr Nicole Saur - University of Pennsylvania, Philadelphia, USA )
29 Nov 2019
New approaches and highlights from SIOG 2019
Dr Hans Wildiers - President, SIOG
New approaches and highlights from SIOG 2019 ( Dr Hans Wildiers - President, SIOG )
29 Nov 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation